We enrolled and completed dosing in the Phase Ib trial in AD patients with data coming in December. We initiated our first of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback